Recruitment in the Age of AI: Fixing Patient Access Without Losing the Human Connection

AI has enormous potential to change clinical trial recruitment, but technology alone won’t solve the patient access problem.

In a new Q&A with Applied Clinical Trials, John Worden, Chief Commercial Officer at Javara, explores how AI, EHR data and care-integrated clinical research can create a more personalized approach to connecting patients with clinical trials.

Key Takeaways on Recruitment in the Age of AI:

• Why clinical trial recruitment remains one-size-fits-all, despite advances in AI and personalized healthcare.
• How AI and EHR data can improve patient identification and trial matching across multiple studies at scale.
• Why physicians still matter. Technology can identify an opportunity, but trusted clinical relationships remain critical to helping patients understand and consider research.
• The patient access problem hiding behind the recruitment problem: patients can’t consider clinical trials they were never made aware of.
• What responsible AI requires in clinical research, including privacy, transparency, governance, human oversight and patient trust.
• What sponsors gain from care-integrated research: more predictable access to qualified patients and an always-on understanding of patient populations rather than one-off recruitment campaigns.
• Where recruitment goes next: combining AI-enabled insights with research embedded into existing healthcare workflows.

The takeaway? The future of clinical trial recruitment isn’t AI replacing the human connection. It’s using AI to make that connection happen earlier, more intelligently and for more patients.

Read the full Q&A in Applied Clinical Trials!